Stay updated on INCB001158 Combo with SC Daratumumab vs Daratumumab SC Clinical Trial
Sign up to get notified when there's something new on the INCB001158 Combo with SC Daratumumab vs Daratumumab SC Clinical Trial page.

Latest updates to the INCB001158 Combo with SC Daratumumab vs Daratumumab SC Clinical Trial page
- Check5 days agoChange DetectedThe clinical trial record is now available with its study design, eligibility criteria, locations, outcome measures, results, and study documents. It reports that the trial was terminated because of recruitment difficulties, with no safety-related concerns cited.SummaryDifference65%

- Check12 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error with a basic header and a Home link, and the surrounding study content appears removed, indicating the study record is currently inaccessible.SummaryDifference19%

Stay in the know with updates to INCB001158 Combo with SC Daratumumab vs Daratumumab SC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCB001158 Combo with SC Daratumumab vs Daratumumab SC Clinical Trial page.